Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 11 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

43%

3 of 7 completed trials have results

Key Signals

1 recruiting3 with results

Enrollment Performance

Analytics

N/A
11(100.0%)
11Total
N/A(11)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)